Abnormalities in lipoprotein metabolism in hemodialysis patients

Slides:

Advertisements

Similar presentations

Reduced renal function in patients with simple renal cysts

Advertisements

Volume 56, Pages S238-S241 (July 1999)

Steven Fishbane, Jeffrey S. Berns, M.D. Kidney International

Volume 65, Issue 6, Pages (June 2004)

KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient Christoph Wanner,

Iron status and iron supplementation in peritoneal dialysis patients

Anemia management in chronic kidney disease

Lipopheresis in the nephrotic syndrome

Estrogen effects on triglyceride metabolism in analbuminemic rats

Ravinder S. Chana, David C. Wheeler Kidney International

C-reactive protein and dialysis access

Volume 55, Issue 2, Pages (February 1999)

Naïve and central memory T-cell lymphopenia in end-stage renal disease

Volume 64, Pages S3-S12 (December 2003)

C-reactive protein and dialysis access

Volume 58, Issue 1, Pages (July 2000)

High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury D.P. Gabriel, J.T. Caramori,

Per-Ola Attman, M.D, Petar Alaupovic, Ola Samuelsson

N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment Martina Franz, Wolfgang Woloszczuk, Walter.

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Nephrology Crosswords: Hemodialysis

Volume 86, Issue 2, Pages (August 2014)

Reducing lipids for CV protection in CKD patients—current evidence

The epidemiology of chronic kidney disease

Volume 87, Issue 2, Pages (February 2015)

Thomas Quaschning, Jan Galle, Christoph Wanner

Edmund G. Lowrie Kidney International

Study of Heart and Renal Protection (SHARP)

Acute myocardial infarction in patients with end-stage renal disease

Volume 61, Issue 1, Pages S106-S109 (January 2002)

Blood pressure targets in hemodialysis patients

Volume 67, Issue 1, Pages (January 2005)

Volume 65, Issue 6, Pages (June 2004)

Endothelial dysfunction and inflammation: What is the link?

Effects of hemodialysis on cardiac function

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Microbiology and outcomes of peritonitis in North America

Alternate-day dialysis may be needed for hemodialysis patients

Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia

AGEs in foods: Do they play a role in uremia?

Volume 87, Issue 1, Pages (January 2015)

Volume 67, Issue 4, Pages (April 2005)

Reduced renal function in patients with simple renal cysts

Simvastatin in nephrotic syndrome

Volume 56, Pages S235-S237 (July 1999)

Volume 56, Pages S213-S215 (July 1999)

Volume 64, Issue 1, Pages (July 2003)

Mediterranean diets: are they practical in the Western world?

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients B. Bammens, P. Evenepoel, H. Keuleers,

The course of the remnant kidney model in mice

Current status of maintenance hemodialysis in Beijing, China

Volume 56, Pages S71-S74 (November 1999)

Volume 72, Issue 2, Pages (July 2007)

Uremic autonomic neuropathy studied by spectral analysis of heart rate

Early detection and prevention of diabetic nephropathy: A challenge calling for mandatory action for Mexico and the developing world Ricardo Correa-Rotter,

Volume 80, Issue 10, Pages (November 2011)

Volume 56, Pages S238-S241 (July 1999)

Volume 80, Issue 10, Pages (November 2011)

Volume 56, Pages S28-S30 (July 1999)

Angiotensin II modulates cellular functions of podocytes

Charles A. Herzog Kidney International

Volume 56, Pages S254-S255 (July 1999)

Volume 70, Issue 3, Pages (August 2006)

Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa

Volume 70, Issue 5, Pages (September 2006)

Volume 56, Pages S171-S173 (July 1999)

Evaluation of the Losartan in Hemodialysis (ELHE) Study

Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis Karl-Georg Fischer, M.D., Andreas van.

Lipoprotein abnormalities in diabetic nephropathy

Presentation transcript:

Abnormalities in lipoprotein metabolism in hemodialysis patients Michaela Königer, M.D., Thomas Quaschning, Christoph Wanner, Peter Schollmeyer, Annette Krämer-Guth Kidney International Volume 56, Pages S248-S250 (July 1999) DOI: 10.1046/j.1523-1755.1999.07166.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Concentration-dependent degradation of 125I-labeled low-density lipoprotein (LDL) by cultures of HepG2 cells. LDL obtained from healthy controls (open bars), LDL obtained from hemodialysis patients (serum triglycerides > 2.28 mmol/liter, dotted bars), and LDL obtained from hemodialysis patients with non–insulin-dependent diabetes mellitus (serum triglycerides > 2.28 mmol/liter, hatched bars). Data are given as mean ±SEM of 10 subjects in every group. All measurements were carried out in triplicate. *P < 0.05 vs. controls. Kidney International 1999 56, S248-S250DOI: (10.1046/j.1523-1755.1999.07166.x) Copyright © 1999 International Society of Nephrology Terms and Conditions